Market revenue in 2023 | USD 3,469.7 million |
Market revenue in 2030 | USD 4,717.6 million |
Growth rate | 4.5% (CAGR from 2023 to 2030) |
Largest segment | Cannabis/marijuana |
Fastest growing segment | Cannabis/Marijuana |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Alcohol, Cannabis/Marijuana, Cocaine, Opioids, Amphetamine & Methamphetamine, LSD, Other Drug Types |
Key market players worldwide | Quest Diagnostics Inc, Abbott Laboratories, Clinical Reference Laboratory, Cordant Health Solutions, ZeOmega, Psychemedics Corp, Millennium HealthCare Inc, Mayo Clinic, Precision Diagnostics, LGC Group, Labcorp Drug Development, Legacy Medical, Drugscan, USDTL |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to drug of abuse testing services market will help companies and investors design strategic landscapes.
Cannabis/marijuana was the largest segment with a revenue share of 24.24% in 2024. Horizon Databook has segmented the North America drug of abuse testing services market based on alcohol, cannabis/marijuana, cocaine, opioids, amphetamine & methamphetamine, lsd, other drug types covering the revenue growth of each sub-segment from 2018 to 2030.
In 2019, North America captured a substantial share of the drug of abuse testing services market, primarily due to the presence of prominent players undertaking extensive expansion strategies. Its dominant share can also be attributed to the increasing prevalence of drug abuse in the region and government initiatives to control it.
Furthermore, increased rate of substance use disorder due to the novel coronavirus (COVID-19) pandemic is anticipated to boost the demand for the drug of abuse testing services in the region. However, nationwide lockdown due to COVID-19 is anticipated to reduce the demand for workplace drug testing services, thus, leading to low market growth.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America drug of abuse testing services market , including forecasts for subscribers. This continent databook contains high-level insights into North America drug of abuse testing services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account